Annexon, Inc. Presents Positive Real-World Evidence for Tanruprubart in Guillain-Barré Syndrome at 2025 PNS Annual Meeting May 19, 2025 — 04:13 pm EDT Written by None for Quiver Quantitative -> ...

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005 ...

About Guillain-Barré Syndrome (GBS) GBS is a rare neuromuscular emergency resulting from an acute autoantibody and classical complement-mediated attack on peripheral nerves that generally occurs ...

SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III ...

About Guillain-Barré Syndrome GBS is a rare neuromuscular emergency resulting from an acute autoantibody and classical complement-mediated attack on peripheral nerves that generally occurs ...

Featuring the striking image of a patient frozen in ice with the header “Guillain-Barré Syndrome can trap your patients for a lifetime,” the campaign draws attention to the life-altering ...